PROFESSIONAL EDITION

The largest community of pharma leaders

Terns Pharmaceuticals Appoints Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer

FOSTER CITY, Calif. & SHANGHAI–(BUSINESS WIRE)–Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, announced today the appointment of Ankang Li, Ph.D., J.D., CFA as Chief Financial Officer. “Dr. Li joins Terns with over 10 years of experience in investment banking, business development, legal advisory, and biomedical research,” said Weidong Zhong, Ph.D., President…

 

 

 

http://www.businesswire.com/news/home/20190701005203/en/Terns-Pharmaceuticals-Appoints-Ankang-Li-Ph.D.-J.D.

Recent Articles